Latest News about LGVN
Recent news which mentions LGVN
Why Longeveron’s Good News Isn’t Telling Us the Whole Truth
December 10, 2021
Tickers
LGVN
From InvestorPlace
18 Stocks Moving in Friday's Pre-Market Session
December 10, 2021
From Benzinga
Mid-Morning Market Update: Markets Open Lower; US Initial Jobless Claims Drop To 52-Year Low
December 09, 2021
From Benzinga
7 Best Drug Stocks to Buy for 2022 Without Covid Catalysts
December 07, 2021
From InvestorPlace
2 Big Stock Bets That Are Insiders Are Buying Now
December 06, 2021
From InvestorPlace
Longeveron Granted Orphan Drug Designation by FDA for Lomecel-B to Treat Infants with Hypoplastic Left Heart Syndrome (HLHS)
December 06, 2021
Tickers
LGVN
From Benzinga
58 Biggest Movers From Friday
December 06, 2021
From Benzinga
Is Longeveron a Good Biotech Stock to Buy?
December 05, 2021
From Motley Fool
Mid-Afternoon Market Update: DocuSign Drops Following Weak Revenue Forecast; Longeveron Shares Climb
December 03, 2021
From Benzinga
Mid-Day Market Update: Nasdaq Dips Over 400 Points; Marvell Technology Shares Rise Following Upbeat Earnings
December 03, 2021
From Benzinga
41 Stocks Moving In Friday's Mid-Day Session
December 03, 2021
From Benzinga
Mid-Morning Market Update: Markets Open Lower; Big Lots Issues Weak Profit Forecast
December 03, 2021
From Benzinga
From InvestorPlace
Longeveron Shares Gain After Lead Product Gets FDA Orphan Drug Tag For Type Of Congenital Heart Defect
December 03, 2021
Tickers
LGVN
From Benzinga
20 Stocks Moving in Friday's Pre-Market Session
December 03, 2021
From Benzinga
61 Biggest Movers From Yesterday
December 02, 2021
From Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
December 01, 2021
From Benzinga
From InvestorPlace
23 Stocks Moving in Wednesday's Pre-Market Session
December 01, 2021
From Benzinga
Longeveron Shares Fall After Raising $20M Capital Via Equity
December 01, 2021
Tickers
LGVN
From Benzinga
Longeveron Announces Clinical Collaboration To Study Cell Therapy Aging Treatment In Japan: Why It Matters
November 30, 2021
Tickers
LGVN
From Benzinga
Even After a Blistering Rally, Longeveron Is Still Buyable
November 30, 2021
Tickers
LGVN
From InvestorPlace
35 Stocks Moving In Tuesday's Mid-Day Session
November 30, 2021
From Benzinga
50 Biggest Movers From Yesterday
November 30, 2021
From Benzinga
56 Biggest Movers From Friday
November 29, 2021
From Benzinga
48 Stocks Moving In Friday's Mid-Day Session
November 26, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.